The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
How will you make your company more attractive to investors?
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
The total value of deals for 2019 exceeds $30 billion.
Overall activity in deals jumped 11% in North America.
Industry consolidation, consumerized medical devices and cybersecurity are the top issues in the year ahead.
Medical device companies have upped their game in product security and regulatory compliance, but they might not be ready for a catastrophic event.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.
Olivier Bohuon says he is not a fan of the concept of big is beautiful, and adds that there’s not much innovation occurring in hip implants.